Paper
RSC Advances
S. France, Chem. Soc. Rev., 2014, 43, 804–818; (c)
T. F. Schneider, J. Kaschel and D. B. Werz, Angew. Chem.,
Int. Ed., 2014, 53, 5504–5523; (d) H. K. Grover,
M. R. Emmett and M. A. Kerr, Org. Biomol. Chem., 2015, 13,
655–671; (e) S. J. Gharpure and L. N. Nanda, Tetrahedron
Lett., 2017, 58, 711–720; (f) P. Singh, R. K. Varshnaya,
R. Dey and P. Banerjee, Adv. Synth. Catal., 2020, 362, 1447–
1484.
3 For reviews, see: (a) M. H. Shaw and J. F. Bower, Chem.
Commun., 2016, 52, 10817–10829; (b) L. Souillart and
N. Cramer, Chem. Rev., 2015, 115, 9410–9464; (c) M. Rubin,
M. Rubina and V. Gevorgyan, Chem. Rev., 2007, 107, 3117–
3179.
Scheme 3 Proposed nucleophilic ring-opening of arylcyclopropanes.
yield.14 It should be noted that 3,3-diaryl-propylamine is
a structural motif found in some pharmaceuticals such as fen-
dilline.15 These one-pot transformations can be considered as
a formal 1,3-oxy arylation or 1,3-amino arylation of the arylcy-
clopropane, which has not been reported so far.
A possible reaction mechanism was depicted in Scheme 3.
Given the reported paper,11 this ring-opening 1,3-arylboration is
suggested to proceed in a stepwise manner. That is, the treat-
ment of BCl3 to aryl cyclopropane could generate a zwitterionic
intermediate i. The following nucleophilic addition of an arene
to benzylic cation could give intermediate ii, which is trans-
formed to pinacol borate by the reaction with pinacol and
triethylamine.
In summary, we have developed a method for the 1,3-aryl-
boration of arylcyclopropanes to provide 3,3-diaryl-propyl
boronic esters for the rst time. It was found that BCl3 was
optimal as the boron source in the presence of arene nucleo-
philes. The formal 1,3-oxy arylation and 1,3-amino arylation of
the arylcyclopropane via one-pot derivatization of the installed
boron group were also achieved. A full account of these studies
will be reported in due course.
4 J. G. M. Morton, M. A. Dureen and D. W. Stephan, Chem.
Commun., 2010, 46, 8947–8949.
5 C. R. Pitts, B. Ling, J. A. Snyder, A. E. Bragg and T. Lectka, J.
Am. Chem. Soc., 2016, 138, 6598–6609.
´
6 (a) N. O. Ilchenko, M. Hedberg and K. J. Szabo, Chem. Sci.,
2017, 8, 1056–1061; (b) S. M. Banik, K. M. Mennie and
E. N. Jacobsen, J. Am. Chem. Soc., 2017, 139, 9152–9155.
7 M. H. Gieuw, Z. Ke and Y.-Y. Yeung, Angew. Chem., Int. Ed.,
2018, 57, 3782–3786.
8 L. Ge, D.-X. Wang, R. Xing, D. Ma, P. J. Walsh and C. Feng,
Nat. Commun., 2019, 10, 4367.
9 A. Roy, V. Bonetti, G. Wang, Q. Wu, H. F. T. Klare and
M. Oestreich, Org. Lett., 2020, 22, 1213–1216.
10 For reviews see: (a) M. J. Ingleson, Synlett, 2012, 23, 1411–
1415; (b) A. Issaian, K. N. Tu and S. A. Blum, Acc. Chem.
Res., 2017, 50, 2598–2609; (c) Y. Li and X.-F. Wu, Angew.
Chem., Int. Ed., 2020, 59, 1770–1774and references therein.
Also, see: (d) A. J. Warner, J. R. Lawson, V. Fasano and
M. J. Ingleson, Angew. Chem., Int. Ed., 2015, 54, 11245–
11249; (e) A. J. Warner, A. Churn, J. S. McGough and
M. J. Ingleson, Angew. Chem., Int. Ed., 2017, 56, 354–358; (f)
Y. Wei, D. Liu, X. Qing and L. Xu, Asian J. Org. Chem.,
2017, 6, 1575–1578; (g) C.-H. Yang, Y.-S. Zhang, W.-W. Fan,
G.-Q. Liu and Y.-M. Li, Angew. Chem., Int. Ed., 2015, 54,
12636–12639.
Conflicts of interest
There are no conicts to declare.
Acknowledgements
This work was nancially supported by a Japan Society for the
Promotion of Science (JSPS) KAKENHI Grant Number
T17K082100 (K. M.) and by a Platform Project for Supporting
Drug Discovery and Life Science Research (Basis for Supporting
Innovative Drug Discovery and Life Science Research (BINDS))
from the AMED under Grant Number JP19am0101084 and
JP20am0101084.
11 D. Wang, X.-S. Xue, K. N. Houk and Z. Shi, Angew. Chem., Int.
Ed., 2018, 57, 16861–16865.
´
12 E. Richmond, J. Yi, V. D. Vukovic, F. Sajadi, C. N. Rowley and
J. Moran, Chem. Sci., 2018, 9, 6411–6416.
13 Z.-Y. Zhang, Z.-Y. Liu, R.-T. Guo, Y.-Q. Zhao, X. Li and
X.-C. Wang, Angew. Chem., Int. Ed., 2017, 56, 4028–4032.
14 H. C. Brown, A. M. Salunkhe and B. Singaram, J. Org. Chem.,
1991, 56, 1170–1175.
References
1 For reviews, see: (a) H. N. C. Wong, M. Y. Hon, C. W. Tse and
Y. C. Yip, Chem. Rev., 1989, 89, 165–198; (b)
O. G. Kulinkovich, Chem. Rev., 2003, 103, 2597–2632.
2 For reviews, see: (a) H.-U. Reissig and R. Zimmer, Chem. Rev.,
2003, 103, 1151–1196; (b) M. A. Cavitt, L. H. Phun and
15 D. I. B. Kerr, J. Ong, N. M. Puspawati and R. H. Prager, Eur. J.
Pharmacol., 2002, 451, 69–77.
This journal is © The Royal Society of Chemistry 2020
RSC Adv., 2020, 10, 37797–37799 | 37799